Client Testimonials
Tolerance Bio has collaborated with VedTechBio to advance our mission in immune system rejuvenation. Their expertise has been crucial in exploring molecular pathways and delivering important insights for our programs. VedTechBio provided extensive support, identifying hundreds of critical associations to enhance our research efforts. Their structured approach and scientific rigor have seamlessly integrated with our vision to tackle age-related immune challenges. We value their contributions and look forward to furthering this impactful partnership.
We have partnered with VedTechBio to support our small molecule drug discovery programs in obesity and diabetes at RenaissThera. Their expertise in designing innovative compounds and managing synthesis and assays through global CROs has been invaluable. VedTechBio's contributions have propelled our discovery efforts forward with precision and efficiency. Their seamless collaboration and scientific insight align perfectly with our mission to address critical challenges in cardio-metabolic diseases.
Since August 2023, ConquestBio has partnered with VedTechBio for critical support across our small molecule drug discovery programs in Cardio-metabolic, Oncology, and Inflammation. Their expertise in target selection, computational biology, and medicinal chemistry has been instrumental in advancing a novel oncology target from design to validated hits; this project is now progressing into lead optimization. They have also led the design and execution of preclinical in vitro and in vivo studies, in addition to efficiently managing CROs across the US, India, Europe, and China. The partnership with VedTechBio has been highly productive and cost-efficient and their work is of highest quality. In short, their seamless logistical and operational support has made them an invaluable extension of our team.
We at AlphaMeld Corporation have partnered with VedTechBio to advance innovation in AI-driven biomedical R&D. Their expertise has been pivotal across diverse initiatives, from therapeutic peptide discovery and compound optimization to preclinical research and IND-enabling studies. VedTechBio's application of AI frameworks and robust workflows has accelerated our projects, delivering comprehensive insights and high-potential candidates within timelines. Additionally, they have also supported us with the management of CROs/CDMOs for GMP-grade API production, preclinical optimization, and detailed target validation in areas like cardiometabolic disorders and rare diseases. Their seamless collaboration and deep scientific acumen make VedTechBio an invaluable partner in our drug discovery mission.